Equities

Talkspace Inc

TALK:NAQ

Talkspace Inc

Actions
Health CareHealth Care Providers
  • Price (USD)3.30
  • Today's Change0.00 / 0.00%
  • Shares traded37.33k
  • 1 Year change+110.19%
  • Beta1.1111
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Talkspace, Inc. is a behavioral healthcare company, which offers access to a fully credentialed network of licensed therapists, psychologists and psychiatrists. Through its platform, the Company provides psychotherapy and psychiatry services to individuals, enterprises and health plans through both business-to-business (B2B) and business-to-customer (B2C) channels. In psychotherapy or talk therapy, members work with a licensed therapist or counsellor to treat specific mental health conditions, such as depression or anxiety, trauma and other human challenges, including by developing positive thinking and coping skills. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized, care from a prescriber who specializes in mental healthcare and prescription management. The Company offers its members a robust ecosystem for end-to-end behavioral healthcare.

  • Revenue in USD (TTM)172.54m
  • Net income in USD-7.66m
  • Incorporated2020
  • Employees472.00
  • Location
    Talkspace Inc622 Third AvenueNEW YORK 10017United StatesUSA
  • Phone+1 (212) 284-7206
  • Fax+1 (302) 655-5049
  • Websitehttps://www.talkspace.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Accolade Inc441.03m-80.10m286.71m2.40k--0.6763--0.6501-1.03-1.035.695.260.5477--17.46183,761.70-9.95-24.80-11.44-29.0448.2445.56-18.16-56.43----0.3308--14.0934.3078.29--31.97--
Viemed Healthcare Inc214.30m10.43m353.15m996.0035.292.839.951.650.2570.2575.283.211.3418.969.53215,161.606.5612.288.4015.5260.2862.574.8810.091.199.020.04890.0031.8223.2164.631.5033.67--
Enhabit Inc1.04bn-116.60m396.74m10.80k--0.7008--0.3825-2.32-2.3220.6511.260.7529--6.5196,037.04-8.28---9.49--48.79---11.00----0.66080.468---2.32---99.26------
DocGo Inc742.84m30.09m409.27m2.92k14.411.298.820.5510.27760.27766.873.101.69--3.95254,832.406.62--9.30--32.97--3.92------0.1202--41.72---80.17------
Sonida Senior Living Inc268.04m-22.53m468.71m2.62k----26.711.75-3.89-3.8926.821.210.4142--32.04102,422.60-2.45-6.63-2.88-8.19-----5.91-18.04---0.16330.9715--7.08-11.1155.74---3.97--
Airsculpt Technologies Inc193.03m-3.42m499.90m346.00--5.8864.792.59-0.0619-0.06193.361.480.9033--62.36557,875.80-1.60---1.81--65.39---1.77----2.620.4541--16.07--69.49------
Talkspace Inc172.54m-7.66m555.10m472.00--4.87--3.22-0.0458-0.04581.030.67821.26--17.28365,546.60-5.58---6.47--47.82---4.44------0.00--25.49--75.92------
Fulgent Genetics Inc290.71m-163.43m588.66m1.18k--0.5192--2.02-5.48-5.489.7237.420.2248--6.36245,527.90-13.2016.70-13.9618.3739.1067.89-58.7329.06----0.00080.00-53.2768.41-217.03--57.08--
Community Health Systems Inc12.55bn-398.00m623.88m61.00k----2.710.0497-3.00-3.0095.32-13.120.87846.085.97205,770.50-1.740.7566-2.150.938184.6083.69-1.980.93451.320.98341.12--2.28-2.47-389.13---2.39--
Agilon Health Inc5.35bn-306.78m757.13m1.12k--1.32--0.1414-0.7574-0.952113.131.402.45--3.954,792,792.00-14.04---36.97--2.00---5.73------0.0572--80.74---112.01------
QDM International Inc4.07m1.08m790.14m5.00730.46203.78703.06194.080.00370.00370.0140.01330.6732--7.38814,230.0017.88--31.49--49.42--26.56----866.350.267--461.81--3,411.87------
InnovAge Holding Corp786.51m-15.96m812.98m2.35k--3.12362.771.03-0.1175-0.11755.791.931.47--17.30334,686.00-3.35-3.72-4.76-4.9017.6420.39-2.28-2.79---2.300.2172--11.0110.4147.54---11.39--
Data as of Nov 08 2024. Currency figures normalised to Talkspace Inc's reporting currency: US Dollar USD

Institutional shareholders

29.97%Per cent of shares held by top holders
HolderShares% Held
Hudson Executive Capital LPas of 01 Sep 202411.34m6.74%
BlackRock Fund Advisorsas of 30 Jun 20247.08m4.21%
The Vanguard Group, Inc.as of 30 Jun 20246.50m3.87%
Goldman Sachs & Co. LLC (Private Banking)as of 30 Jun 20245.02m2.99%
Shannon River Fund Management LLCas of 30 Jun 20244.79m2.85%
Kent Lake Capital LLCas of 30 Jun 20244.00m2.38%
AWM Investment Co., Inc.as of 30 Jun 20243.31m1.97%
Divisadero Street Capital Management LPas of 30 Jun 20243.11m1.85%
Geode Capital Management LLCas of 30 Jun 20243.06m1.82%
J. Goldman & Co. LPas of 30 Jun 20242.19m1.30%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.